Melissa Joseph
Physician Assistant · Grand Rapids, MINPI 1366814931
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by AbbVie at 37.2% of the total. 2025 is the largest year on record at $43,186, more than ten times the $2,292 reported in 2021. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 782 payments — averaging $105.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$31K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$26K
- Alkermes, Inc.$10K
- Axsome Therapeutics, Inc.$7K
- Neurocrine Biosciences, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- plus $5K from 17 others
What the payments were for
- Consulting fees$11,89814%
- Speaking & faculty fees$48,18859%
- Travel & lodging$4,9126%
- Food & beverage$16,79820%
- Education$4781%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 169 | $30,611 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 188 | $26,028 |
| Alkermes, Inc. | 70 | $10,185 |
| Axsome Therapeutics, Inc. | 15 | $6,687 |
| Neurocrine Biosciences, Inc. | 68 | $2,400 |
| Otsuka America Pharmaceutical, Inc. | 64 | $1,862 |
| Teva Pharmaceuticals USA, Inc. | 54 | $1,712 |
| Indivior Inc. | 45 | $701 |
| Lundbeck LLC | 32 | $490 |
| Supernus Pharmaceuticals, Inc. | 29 | $343 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $293 |
| Braeburn Inc. | 6 | $209 |
| USWM, LLC | 7 | $143 |
| Orexo US, Inc. | 6 | $119 |
| Sage Therapeutics, LLC | 1 | $113 |
| Johnson & Johnson | 2 | $94 |
| Inspire Medical Systems, Inc. | 1 | $92 |
| Eisai Inc. | 1 | $82 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Pear Therapeutics (US), Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$34,128
- VRAYLAR$28,477
- CAPLYTA$22,232
- Auvelity$6,402
- INGREZZA$1,278
- ARISTADA$973
- REXULTI$500
- ABILIFY MAINTENA$375
- AUSTEDO$364
- ABILIFY ASIMTUFII$250
- ARISTADA INITIO$243
- Austedo XR$213
- BRIXADI$133
- VIVITROL$101
How this compares
$82,272 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 18 | $47,459 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 20 | $5,357 |
| Clozapine | 22 | $4,721 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 53 | $3,521 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 19 | $3,100 |
| Oxcarbazepine | 11 | $1,373 |
| Gabapentin | 17 | $410 |
| Quetiapine Fumarate | 12 | $332 |
| Bupropion XlBupropion Hcl | 13 | $329 |
| Aripiprazole | 14 | $206 |
| Lorazepam | 24 | $129 |
| Trazodone Hcl | 11 | $107 |
| Lamotrigine | 12 | $80 |
| Benztropine Mesylate | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $1,862 | $47,45918 claims |
| Orexo US, Inc.Zubsolv | $119 | $5,35720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Grand Rapids
- Erin van DykeGrand Rapids$346K
- Matthew SchultzGrand Rapids$49K
- Shannon ToddGrand Rapids$32K
- Patrick HandlinGrand Rapids$28K
- John MulderGrand Rapids$27K
- Ginger BiesbrockGrand Rapids$25K
- Matthew ZoetemanGrand Rapids$23K
- Aaron ZarnoskyGrand Rapids$22K
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.